Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

If you have a question about this talk, please contact Sarah Noujaim.

GUEST SPEAKER

Cardiac ryanodine receptors (RYR2) have been reported to be decreased in disease states, including diabetes and heart failure, and perhaps also as a consequence of aging. The goal of our studies is to unequivocally define the effect of losing 50% of the ryanodine receptor proteins in the heart to help answer several long-standing questions in the field. The first objective of was to determine whether having a full complement of ryanodine receptor channels is really important for setting heart rate and whether a partial reduction in these channels would, by itself, result in lethal arrhythmias. The second objective was to determine whether these ryanodine receptor channels play an important role in the organization of the heart muscle cells. The third objective was to find out whether a partial loss of ryanodine receptor channels alters the way heart cells store and use energy from fats versus carbohydrates. We are also interested to how the energy status of the heart cells controls whether the cells decide to commit ‘cell suicide’. Collectively, this new information will help us understand the exact causes of heart failure, diabetic heart disease and arrhythmia, and inform efforts to stop these diseases.